Event Details
April 01, 2013
Description
Chimerix IPO
Participants (2)
| Name | Type | Mentions | |
|---|---|---|---|
| NLV-II | person | 0 | View Entity |
| Chimerix | organization | 8 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024045.jpg
Investment Report / Confidential Memorandum (House Oversight Evidence)
• 2.72 MB
This document is a confidential investment report page (marked House Oversight) detailing the track record of New Leaf Ventures (NLV) in the biopharmaceutical sector. It highlights their investment strategy, networking capabilities, and specific performance metrics (multiples on invested capital) for various portfolio companies across funds NLV-I, NLV-II, and Sprout Funds. The text lists specific exits and IPOs occurring between 2011 and 2013.
Event Metadata
Type
Unknown
Location
NASDAQ
Significance Score
5/10
Participants
2
Source Documents
1
Extracted
2025-11-20 19:46
Additional Data
Source
HOUSE_OVERSIGHT_024045.jpg
Date String
April, 2013
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event